TWST
Twist Bioscience Corp
NASDAQ: TWST · HEALTHCARE · DIAGNOSTICS & RESEARCH
$56.70
-4.14% today
Updated 2026-04-29
Market cap
$3.48B
P/E ratio
—
P/S ratio
8.88x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$23 – $66
Volume
1.2M
Twist Bioscience Corp (TWST) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$56.70
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$127.53
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.2B | $0.2B | $0.3B | $0.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -19.60%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.